Lanzhou Foci Pharmaceutical Co., Ltd. Class A

Lanzhou Foci Pharmaceutical Co., Ltd. Class A

SSZSE:002644
7.72
CNY
+0.01
(+0.13%)
3.48BMarket Cap

Latest Stock Split

Aug 14, 2015

5:2

For every 2 shares held, investors received 5. The price per share adjusted from $63.00 to $25.20.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Aug 14, 2015
    Before$63.00
    Split ratio5:2
    After$25.20
    Forward
  2. May 21, 2014
    Before$32.00
    Split ratio2:1
    After$16.00
    Forward
  3. Jun 06, 2012
    Before$16.12
    Split ratio11:10
    After$14.65
    Forward

About Lanzhou Foci Pharmaceutical Co., Ltd. Class A stock splits

Lanzhou Foci Pharmaceutical Co., Ltd. Class A (SZSE:002644) operates in the Pharmaceuticals: other industry.

Lanzhou Foci Pharmaceutical Co., Ltd. Class A company overview

When did Lanzhou Foci Pharmaceutical Co., Ltd. Class A stock split?

Lanzhou Foci Pharmaceutical Co., Ltd. Class A's most recent stock split was on August 14, 2015. It was a 5-for-2 forward split, so shareholders received 5 shares for every 2 they held.

What is Lanzhou Foci Pharmaceutical Co., Ltd. Class A's stock split history?

Lanzhou Foci Pharmaceutical Co., Ltd. Class A (SZSE:002644) has split its stock 3 times: a 11-for-10 split on June 6, 2012, a 2-for-1 split on May 21, 2014, and a 5-for-2 split on August 14, 2015.

How many times has Lanzhou Foci Pharmaceutical Co., Ltd. Class A stock split?

Lanzhou Foci Pharmaceutical Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between June 6, 2012 and August 14, 2015.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Lanzhou Foci Pharmaceutical Co., Ltd. Class A's 5-for-2 split on August 14, 2015, every 2 shares became 5 shares.

Will Lanzhou Foci Pharmaceutical Co., Ltd. Class A split its stock again?

Lanzhou Foci Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on August 14, 2015, 11 years ago. Companies announce splits in advance, and any new SZSE:002644 split will appear on this page.